TRXB logo

TRex Bio Inc.

TRXB
Healthcare|Medical - Pharmaceuticals|US
$13.26
+0.27 (+2.08%)
Financing Filings (last 12 months)
3
Shelf registrations / offering prospectuses — latest Oct 9, 2026 (424B4). Possible dilution.

Upcoming Data Readouts (1)

Sep 2027
Est. completion
P1Moderate-to-severe Atopic Dermatitis
Phase 1a/1b Study of TRB-061 in Healthy Participants & Patients With Atopic Dermatitis
NCT06934252n=115

Recent Press Releases

TRexBio Announces Closing of Initial Public Offering
Oct 13, 2026 · GlobeNewsWire
TRexBio Announces Pricing of Initial Public Offering
Oct 8, 2026 · GlobeNewsWire

SEC Filings (15)

Last two years from EDGAR. Insider Form 4s are on the Ownership tab.

FiledFormWhat it isLinks
Oct 16, 2026SC 13GPassive 5%+ stakeDocumentIndex
Oct 16, 2026SC 13DActivist / 5%+ stakeDocumentIndex
Oct 16, 2026SC 13DActivist / 5%+ stakeDocumentIndex
Oct 15, 2026SC 13GPassive 5%+ stakeDocumentIndex
Oct 13, 20268-KMaterial eventDocumentIndex
Oct 9, 2026S-8Employee stock planDocumentIndex
Oct 9, 2026424B4Offering prospectusDocumentIndex
Oct 8, 2026EFFECTDocumentIndex
Oct 8, 2026CERTDocumentIndex
Oct 6, 20268-A12BDocumentIndex
Oct 5, 2026S-1/AIPO / offering registrationDocumentIndex
Sep 18, 2026S-1IPO / offering registrationDocumentIndex
Aug 21, 2026DRS/ADocumentIndex
Jul 31, 2026DRS/ADocumentIndex
Jun 26, 2026DRSDocumentIndex